IS EBV-EBNA-1 IGG ELISA TEST SYSTEM— 510(k) K981829

Substantially Equivalent

Diamedix Corp.

FDA 510(k) clearance K981829 for IS EBV-EBNA-1 IGG ELISA TEST SYSTEM, Substantially Equivalent on 1999-02-16. Applicant: Diamedix Corp..

Clearance details

Applicant
Diamedix Corp.
Product code
Code GNP
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Columbia, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.